Sorcero Raises $42.5M Series B to Accelerate AI‑Driven Life Sciences Platform

Why It Matters

The infusion of capital positions Sorcero to scale its AI platform at a time when drug developers are seeking faster, data‑driven insights, potentially reshaping how the life‑sciences industry extracts value from complex scientific data.

Deal Summary

Sorcero, an AI‑powered intelligence platform for life sciences, announced a $42.5 million Series B round led by NewSpring Growth. The funding will support product expansion and go‑to‑market initiatives. NewSpring Growth joins existing backers to help Sorcero scale its SaaS offering for biotech and pharma customers.